Brief: Tenax Granted Notice Of Allowance For U.S. Patent Application Pulmonary Hypertension Drug

Tenax Therapeutics

02/02/2023 24:02

Feb 1 (Reuters) - Tenax Therapeutics Inc  TENX.O :
    * TENAX GRANTED NOTICE OF ALLOWANCE FOR U.S. PATENT
APPLICATION
COVERING USE OF IV LEVOSIMENDAN IN PULMONARY HYPERTENSION WITH
HEART FAILURE AND PRESERVED EJECTION FRACTION (PH-HFPEF)

Source text for Eikon:  ID:nGNX4RWQRh 
Further company coverage:  TENX.O 
 ((Reuters.Briefs@thomsonreuters.com))